Hyun W. Bae

Executive

US·SEC (Form 4)

Kairos Pharma, Ltd.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 23 Dec 2025 for Kairos Pharma, LTD.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Hyun W. Bae: trading record in brief

All filings by Hyun W. Bae on record concern Kairos Pharma, Ltd. Between 16 September 2025 and 8 October 2025, the trades on record add up to 2 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 23 December 2025 came the latest disclosure, a share grant in Kairos Pharma, Ltd. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.